focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 526.00
Bid: 522.00
Ask: 524.00
Change: 11.00 (2.14%)
Spread: 2.00 (0.383%)
Open: 512.00
High: 526.00
Low: 512.00
Prev. Close: 515.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

27 Jan 2012 07:00

RNS Number : 2733W
Creston PLC
27 January 2012
 



 

 

27 January 2012

 

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 October 2011 to date.

 

Trading update

 

For the three months to 31 December 2011 (the 'Period'), the Group reported revenue growth of over 22 per cent compared to the same period last year. Like-for-like1 revenue growth for the third quarter was 7 per cent, compared to the same period in the prior year. Year to date, like-for-like revenue growth of 5 per cent has been achieved.

 

Despite this revenue growth, the Board's expectation for Headline2 PBIT3 for the full year is lowered to be slightly below that of the prior year. The anticipated reduction in Headline PBIT is as a result of a shortfall in fourth quarter new business, the costs associated with staffing-up to service the expected increase in revenue, client projects being delayed until the new financial year and operating losses associated with the start-up ventures in the year. Appropriate actions have begun to align operating costs to the lower expected sales levels, the effects of which will predominantly be realised from the start of the new financial year.

 

Insight

 

The Insight division had a good third quarter growth in revenue, which exceeded the preceding second quarter as well as quarter three of the prior year. This growth has been achieved by the addition of new clients in the first half of the year, such as the BBC and others, which cannot currently be named. In the Period, the division established Vitaris, a new healthcare research consultancy, targeting new and existing health clients. This new product offering was launched later than expected and accordingly the contribution to the current financial year will be below original expectations. This business is expected to be margin accretive in the next financial year.

 

Although the Insight division's performance to date has shown positive revenue growth, the Board expects a revenue decline for the ICM business in the fourth quarter caused by a shortfall in new business and a delay of projects into the new financial year. This is disappointing considering the improving performance of the Insight division and the new client wins earlier in the year. The necessary actions are being taken to align operating costs to the lower expected level of sales for the remainder of this, and future financial years. However, the savings generated from actions already underway will have minimal impact in the current financial year and the revenue decline will have a direct impact on fourth quarter profitability.

 

Communications

 

The Communications division has continued its positive revenue growth in the third quarter versus the first half of the year and compared to the same period last year. This growth has been achieved due to the successful addition of new clients, such as Brother, Open University, Sue Ryder and the continued expansion of activity for existing clients, such as the successful addition to the Unilever European digital roster.

 

The growth in full year revenue for the Communications division is broadly in line with the Board's expectations, however, this incremental revenue will not fully convert to PBIT due to the slower than budgeted financial performance of the start-ups during the year, such as Creston Unlimited and the Nelson Bostock Group's public relations office in Hong Kong. Whilst such organic initiatives are generally loss making in their first year of trading, this strategy of investing in start-ups remains important to the long term growth of the division.

 

Health

 

TheHealth division has materially increased its revenue and PBIT in the third quarter versus the prior year, due to the growth of its presence in the US. The addition of the US public relations companies to the division has strengthened its global PR capability and as a consequence there are an increasing number of on-going global pitches, in addition to the recent World Hepatitis Alliance win.

 

Additionally, the division's new local health offer (launched as Grapevine in the second quarter) has already won its first client and is set to benefit from the Government's recent announcement to ring fence £5 billion for local government public health.

 

The decline however in new business opportunities announced in the first half of the year has had the expected impact on the third quarter with a small like-for-like revenue decline. While there has been an improvement in new business opportunities during the second half with some new client wins, this will not have as big an impact this financial year as was expected. In addition, fourth quarter delays to client budgets are also expected to push further revenue back into the next financial year.

 

Outlook

 

The Group has reported good like-for-like revenue growth of 7 per cent in the third quarter and although the full year like-for-like and reported revenue growth is expected to be positive, fourth quarter revenue will be lower than the Board's expectations. Despite this revenue growth, Headline PBIT is expected to be slightly below that of the prior year as detailed above. Since the Group's performance was weighted to the second half of the year and especially the fourth quarter, the cost reductions that have been implemented will have minimal impact on this financial year, but will improve profitability on future revenue.

 

 

 

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson

 

 

 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including digital marketing, market research, health communications, public relations, direct marketing, advertising and brand consultancy to a broad spectrum of blue-chip clients. All our companies share a common commitment to understanding, influencing and inspiring consumers on behalf of our clients and to creating value through innovative collaborative working. www.creston.com

 

 


1 Like-for-like compares current year performance to prior year performance, excluding the results from any acquisitions.

 

2 Headline results reflect the underlying performance of the Group and excludes acquisition, start-up and restructuring related costs, deemed remuneration charges and notional finance costs.

 

3 Profit before finance income, finance costs and taxation (PBIT).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAFFKADLAEAF
Date   Source Headline
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results
17th Feb 20237:00 amRNSAppointment of Corporate Brokers
2nd Feb 20237:00 amRNSNotice of 2022 Results and Conference Call
25th Jan 20237:00 amRNSJanuary 2023 Renewals Trading Update
20th Jan 20232:00 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSNotice of 1 Jan 23 Renewals Trading Update Call
23rd Dec 20229:17 amRNSConduit Re welcomes AM Best affirming A- rating
20th Dec 20227:00 amRNSConduit Re welcomes AMBest affirmation of A rating
9th Nov 20227:00 amRNSThird Quarter 2022 Trading Update
3rd Nov 20227:00 amRNSNotice of Q3 2022 Trading Update
29th Sep 20225:23 pmRNSPurchase of Shares by Employee Benefit Trust
26th Sep 20221:36 pmRNSPurchase of Shares by Employee Benefit Trust
16th Sep 20225:40 pmRNSTransaction in Own Shares
7th Sep 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.